About: Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers
Creator	Custer, Brian Stramer, Susan Anderson, Steven Kamel, Hany Roger, \| Shaz, Beth Bialkowski, \| Crowder, Lauren Dodd, Y Farnaz Vahidnia, \| Gottschall, L Hinkins, Susan Jerome, \| Kessler, Debra Leparc, German Rebosa, Mark Steele, Whitney Stern, \| Walderhaug, Mark Whitaker, Barbee
Source	Medline; PMC
abstract	Risk assessments of transfusion‐transmitted emerging infectious diseases (EIDs) are complicated by the fact that blood donorsʼ demographics and behaviors can be different from the general population. Therefore, when assessing potential blood donor exposure to EIDs, the use of general population characteristics, such as U.S. travel statistics, may invoke uncertainties that result in inaccurate estimates of blood donor exposure. This may, in turn, lead to the creation of donor deferral policies that do not match actual risk. STUDY DESIGN AND METHODS: This article reports on the development of a system to rapidly assess EID risks for a nationally representative portion of the U.S. blood donor population. To assess the effectiveness of this system, a test survey was developed and deployed to a statistically representative sample frame of blood donors from five blood collecting organizations. Donors were directed to an online survey to ascertain their recent travel and potential exposure to Middle East respiratory syndrome coronavirus (MERS‐CoV). RESULTS: A total of 7128 responses were received from 54 256 invitations. The age‐adjusted estimated total number of blood donors potentially exposed to MERS‐CoV was approximately 15 640 blood donors compared to a lower U.S. general population‐based estimate of 9610 blood donors. CONCLUSION: The structured donor demographic sample–based data provided an assessment of blood donorsʼ potential exposure to an emerging pathogen that was 63% larger than the U.S. population–based estimate. This illustrates the need for tailored blood donor–based EID risk assessments that provide more specific demographic risk intelligence and can inform appropriate regulatory decision making.
has issue date	2020-08-03(xsd:dateTime)
bibo:doi	10.1111/trf.15941
bibo:pmid	32743798
has license	no-cc
sha1sum (hex)	e6f3d0cee9cd96b3b69b16dcdde9111e99792737
schema:url	https://doi.org/10.1111/trf.15941
resource representing a document's title	Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers
has PubMed Central identifier	PMC7436713
has PubMed identifier	32743798
schema:publication	Transfusion
resource representing a document's body	covid:e6f3d0cee9cd96b3b69b16dcdde9111e99792737#body_text
is schema:about of	named entity 'survey' named entity 'representative' named entity 'Background' named entity 'BLOOD' named entity 'representative' named entity 'blood' named entity 'blood donors' named entity 'survey methodology' named entity 'emerging infectious diseases' named entity 'representative sampling' named entity 'organizations' named entity 'text message' named entity 'FDA' named entity 'blood donors' named entity 'blood supply' named entity 'transmissibility' named entity 'Middle East respiratory syndrome-coronavirus' named entity 'general population' named entity 'demographic information' named entity 'MERS-CoV' named entity 'endemic areas' named entity 'Department of Health and Human Services' named entity 'USPHS' named entity 'blood supply' named entity 'transfusion' named entity 'UNWTO' named entity 'IRBs' named entity 'donating blood' named entity 'U.S.' named entity 'allogeneic' named entity 'anonymized data' named entity 'MERS-CoV' named entity 'assessment of the risk' named entity 'personally identifying information' named entity 'University of Chicago' named entity 'respiratory illness' named entity 'Europe' named entity 'Study Design' named entity 'Epidemiology' named entity 'blood donor' named entity 'blood donors' named entity 'demographic information' named entity 'demographic' named entity 'donating blood' named entity 'stratified sampling' named entity 'U.S. Food and Drug Administration' named entity 'immunization' named entity 'emerging infectious diseases' named entity 'electronic media' named entity 'blood donors' named entity 'missing data' named entity 'cell phone' named entity 'risk assessment' named entity 'apheresis' named entity 'Saudi Arabia' named entity 'MERS-CoV' named entity 'landing page' named entity 'endemic areas' named entity 'sampling' named entity 'convenience sample' named entity 'electronic media' named entity 'blood donor'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software